Literature DB >> 25532416

Australian Liver Association (ALA) expert consensus recommendations for the use of transient elastography in chronic viral hepatitis.

William Kemp1, Miriam Levy, Martin Weltman, John Lubel.   

Abstract

Since the introduction of Transient Elastography (TE) into Australia in 2008, non-invasive liver fibrosis assessments have integrated themselves into clinical hepatology. The Australian Liver Association (ALA) recognizes these technologies perform an important role in the assessment of chronic viral hepatitis B and C. However, in the setting of viral hepatitis and many other chronic liver diseases, there remains no consensus or guidelines regarding the performance, utility or reporting of TE. Accordingly, the ALA sought to produce an expert consensus statement for the use of TE in chronic viral hepatitis. The recommendations incorporated in this document are based upon a thorough literature review and draw on extensive clinical experience using TE. The initial draft was presented at Australian Gastroenterology Week (AGW) 2013. Through a collaborative process and expert external review a finalized document was presented at AGW 2014.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  clinical; hepatitis B; hepatitis C; hepatology; liver fibrogenesis; public policy; viral hepatitis

Mesh:

Year:  2015        PMID: 25532416     DOI: 10.1111/jgh.12865

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

Review 1.  Managing hepatitis C in general practice.

Authors:  Simone I Strasser
Journal:  Aust Prescr       Date:  2017-04-03

2.  The Prevalence and Determinants of Hepatic Steatosis Assessed by Controlled Attenuation Parameter in Thai Chronic Hepatitis C Patients.

Authors:  A Sirinawasatien; T Techasirioangkun
Journal:  Gastroenterol Res Pract       Date:  2020-11-02       Impact factor: 2.260

3.  Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study.

Authors:  Jane Davies; Emma L Smith; Margaret Littlejohn; Rosalind Edwards; Vitina Sozzi; Kathy Jackson; Katie Mcguire; Paula Binks; Benjamin C Cowie; Stephen Locarnini; Joshua S Davis; Steven Y C Tong
Journal:  Open Forum Infect Dis       Date:  2019-11-03       Impact factor: 3.835

Review 4.  Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Da-Wu Zeng; Jing Dong; Yu-Rui Liu; Jia-Ji Jiang; Yue-Yong Zhu
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

5.  AASLD guidelines for treatment of chronic hepatitis B.

Authors:  Norah A Terrault; Natalie H Bzowej; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; M Hassan Murad
Journal:  Hepatology       Date:  2015-11-13       Impact factor: 17.425

6.  Feasibility study and reference values of FibroScan 502 with M probe in healthy preschool children aged 5 years.

Authors:  Jing Zeng; Xi Zhang; Chao Sun; Qin Pan; Wen-Yi Lu; Qian Chen; Li-Su Huang; Jian-Gao Fan
Journal:  BMC Pediatr       Date:  2019-04-24       Impact factor: 2.125

7.  Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease.

Authors:  Qiang Li; Chenlu Huang; Wei Xu; Qiankun Hu; Liang Chen
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

8.  Controlled attenuation parameter value-based diagnostic algorithm improves the accuracy of liver stiffness measurement in chronic hepatitis B patients.

Authors:  Yaoxin Fan; Lin Wang; Yang Ding; Qiuju Sheng; Chong Zhang; Yanwei Li; Chao Han; Xiaoguang Dou
Journal:  Aging (Albany NY)       Date:  2020-08-24       Impact factor: 5.682

9.  Prevalence and Determinants of Significant Liver Fibrosis by Vibration-Controlled Transient Elastography in Thai Chronic Hepatitis B Patients.

Authors:  Apichet Sirinawasatien; Thanaya Techasirioangkun; Siriporn Thongsri
Journal:  Int J Hepatol       Date:  2018-10-02

10.  Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.

Authors:  Timothy Papaluca; Anne Craigie; Lucy McDonald; Amy Edwards; Michael MacIsaac; Jacinta A Holmes; Matthew Jarman; Tanya Lee; Hannah Huang; Andrew Chan; Mark Lai; Vijaya Sundararajan; Joseph S Doyle; Margaret Hellard; Mark Stoove; Jessica Howell; Paul Desmond; David Iser; Alexander J Thompson
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.